Contraceptive efficacy and safety of a monophasic oral contraceptive containing 150 μg desogestrel and 30 μg ethinyl estradiol: United States clinical experience using a “Sunday start” approach**Supported by organon Inc., West Orange, New Jersey.
- 1 August 1995
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 64 (2) , 261-266
- https://doi.org/10.1016/s0015-0282(16)57720-6
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- A multicenter efficacy and safety study of an oral contraceptive containing 150 μg desogestrel and 30 μg ethinyl estradiolContraception, 1992
- The Effects of Different Formulations of Oral Contraceptive Agents on Lipid and Carbohydrate MetabolismNew England Journal of Medicine, 1990
- Multicenter Trial of a Monophasic Oral Contraceptive Containing Ethinyl Estradiol and DesogestrelActa Obstetricia et Gynecologica Scandinavica, 1988
- Serum levels of 3-keto-desogestrel after oral administration of desogestrel and 3-keto-desogestrelContraception, 1986
- Binding of progestagens to receptor proteins in MCF-7 cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1983
- Metabolism of a new synthetic progestagen, Org 2969, in female volunteers. The distribution and excretion of radioactivity after an oral dose of the labelled drugActa Endocrinologica, 1980